Mallory Morales - 11 Aug 2022 Form 3 Insider Report for Immuneering Corp (IMRX)

Role: Vice President, Finance
Signature: /s/ Michael D. Bookman, Attorney-in-Fact for Mallory Morales
Issuer symbol: IMRX
Transactions as of: 11 Aug 2022
Net transactions value: $0
Form type: 3
Filing time: 11 Aug 2022, 08:48:02 UTC
Next filing: 17 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IMRX	Class A Common Stock						2,434	11 Aug 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IMRX	Stock Option							11 Aug 2022	Class A Common Stock	25,480	$9.74	Direct	F1
holding	IMRX	Stock Option							11 Aug 2022	Class A Common Stock	23,850	$9.66	Direct	F2
holding	IMRX	Stock Option							11 Aug 2022	Class A Common Stock	5,000	$5.41	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable as to 25% of the underlying shares on May 10, 2022 and then in equal monthly installments over the subsequent three years, subject to Ms. Morales' continued employment through each applicable vesting date.
F2	The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026.
F3	The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on July 31, 2022, and will be fully vested and exercisable on June 30, 2026.